Submission of Annual Secretarial Compliance Report for the financial year ended 31 March 2026 (2025-2026).
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tatva Chintan Pharma Chem Ltd has submitted its Annual Secretarial Compliance Report for FY 2025-26, as required under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report was prepared by TNT & Associates, Practicing Company Secretaries, Vadodara. The report confirms that the company has fully complied with all applicable SEBI regulations, including LODR, SAST, PIT, and Depositories regulations. No deviations, penalties, or non-compliance observations were found during the review period. No actions were taken by SEBI or Stock Exchanges against the company. The previous year's report also had no observations, indicating consistent compliance. The filing was digitally signed by Ishwar Nayi, Company Secretary and Compliance Officer.
This is a positive compliance filing showing the company maintains good corporate governance standards. No impact on shareholders or stock price expected, as no violations or penalties were reported.